Long-Acting Drug Delivery Technologies for Meloxicam as a Pain Medicine.

Abstract

Meloxicam, a selective COX-2 inhibitor, has demonstrated clinical effectiveness in managing inflammation and acute pain. Although available in oral and parenteral formulations such as capsule, tablet, suspension, and solution, frequent administration is necessary to maintain therapeutic efficacy, which can increase adverse effects and patient non-compliance. To address these issues, several sustained drug delivery strategies such as oral, transdermal, transmucosal, injectable, and implantable drug delivery systems have been developed for meloxicam. These sustained drug delivery strategies have the potential to improve the therapeutic efficacy and safety profile of meloxicam, thereby reducing the frequency of dosing and associated gastrointestinal side effects. The choice of drug delivery system will depend on the desired release profile, the target site of inflammation, and the mode of administration. Overall, meloxicam sustained delivery systems offer better patient compliance, and reduce the side effects, thereby improving the clinical applications of this drug. Herein, we discuss in detail different strategies for sustained delivery of meloxicam.

• Authors: Manjusha Annaji, Nur Mita, Jessica Heard, Xuejia Kang, Ishwor Poudel, Sai H S Boddu, Amit K Tiwari, R Jayachandra Babu
• Journal: Critical reviews in therapeutic drug carrier systems (Crit Rev Ther Drug Carrier Syst) Vol. 41 Issue 5 Pg. 111-150 ( 2024) ISSN: 2162-660X [Electronic] United States
• PMID: 38608134 (Publication Type: Journal Article)

Chemical References

• Meloxicam
• Analgesics

Topics

• Humans
• Meloxicam
• Analgesics
• Drug Delivery Systems
• Acute Pain
• Inflammation